4 курс / Акушерство и гинекология / M_Капанадзе_Д_Л_Акушерские_и_перинатальные_исходы_у_беременных_с

СПИСОК ЛИТЕРАТУРЫ

1.Абаева И.Ш., Баймурадова С.М., Бицадзе В.О. РОЛЬ ПРОВОСПАЛИТЕЛЬНЫХ ЦИТОКИНОВ В ПАТОГЕНЕЗЕ СИНДРОМА ПОТЕРИ ПЛОДА

2.Баймурадова С.М. , Бицадзе В.О., Матвеева Т.Е., и др. АФС и генетические формы тромбофилии у беременных с гестозами// Акуш. И гинеколо., 2004.-

номер2-С 21-27

3.Бицадзе В.О. Патогенетическое обоснование применения низкомолекулярных гепаринов у беременных с заболеваниями сердца и тромбофилией.// Дис….канд.мед.наук.М.2000.

4.Баркаган З.С. клинико-патологические варианты, номенклатура и основы диагностики гематогенных тромбофилий ..// Проблемы гематологии, 1996.-

С.5-15.

5.Баркаган З.С. Лычев В.Г. Распознавание синдрома диссеменированного внутрисосудистого свертывания. Методология и экспертная оценка // Лаб.Дело, 1989.-номер 7-с.

6.Краснопольский В. И., Серова О. Ф. Влияние инфекций на репродуктивную систему женщин // Рос. вестн. акушера-гинеколога. 2004. №

5.С. 11–16.

7.Руководство по амбулаторно-поликлинической помощи в акушерстве и гинекологии[с прил. на компакт-диске]/ред. В.И.Кулакова, В.Н.Прилепская, В. Е. Радзинский. М.: Геотар-Медиа, 2007. 1027 с.

8.Макацария А Д , Бицадзе В О . Тромбофилические состояния в акушерской практике .М. РУССО ,2001-704 стр

101

9.Макацария А.Д., Пшеничникова Е.Б.. Пшеничникова Т.Б., Бицадзе В.О. Метаболический синдром и тромбофилия в акушерстве и гинекологии. М МИА, 2006.-87с

10.Макацария А.Д. Бицадзе В.О. Баймурадова С. М. Долгушина Н.В. Юдаева Л.С. Хизроева Д.Х. Акиньшина С. В. Антифосфолипидный синдром

– иммунная тромбофилия в акушерстве и гинекологии. М. триада-х 2007-456

11.Макацария А.Д. Белобарадова Е.В. Баймурадовы С.М. Бицадзе В.О. Гипергомоцистеинемия и осложнения беременности.

12.Подзолкова Н.М.и др.Комплексное морфологическое изучение роли инфекционных процессов в этиологии неразвивающейся беременности//Мать и дитя: материалы VI Рос.форума.М.,2003. С.171.

13.Пестрикова Т. Ю., Юрасова Е. А., Бутко Т. М. Перинатальные потери резервы снижения. М.: Литтера, 2008. 199 с.

14.Сидельникова В. М. Привычная потеря беременности. М.: Триада-Х, 2002. 304 с.

15.Старостина Т. А. и др. Современные вопросы патогенеза и терапии невынашивания беременности // Акушерство и гинекология. 2002. № 5. С.

59–61.

16. Суханова Л. П. Количественные перинатальные показатели в оценке репродуктивного потенциала России на рубеже веков // Материалы IV съезда Российской ассоциации специалистов перинатальной медицины. М., 2002. С.

63–65.

17. Сидельникова В.М. Привычная потеря беременности // М Триада-

Х.2000.304с.

102

18. Серов В.Н., Макацария А.Д. Тромботические и геморрагические осложнения в акушерстве.-М -1987.-288с.

19.Agnelli G, Becattini C (July 2010). "Acute pulmonary embolism". N. Engl.J.Med. 363 (3):266-74.

20.Alarcon-Segovia D, Delete M, Oria CV, Sanchez-Guerrero J, Gomet-Pacheco L, Cabiedes I, Fernandez L, Ponce de Leon S: Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus: a prospective analysis of 500 consecutive patients. Medicine 1989, 68:353-365.

21.Asherson RA, Khamashta MA, Ordi-Ros J, Derksen RHWM, Machin SJ, Barquinero J, Outt HH, Harris EN, Vilardell-Torres M, Hughes GR: The "primary"

anti-phospholipid syndrome: major clinical and serological features. Medicine 1989, 68:366-374.

22. Bertina RM, Koeleman BP, Koster T, et al. (May 1994). "Mutation in blood coagulation factor V associated with resistance to activated protein C". Nature 369 (6475):

23. Bertina RM, Koeleman RPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994, 369:64-67.

24. Branch DW, Silver RM, Pierangeli S, van Leeuwen I, Harris EN: Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and anliphospholipid syndrome. Obstet Gynecol 1997, 89:549-555.

25. Bocciolone L, Meroni P, Parazrini F, Tincani A, Radici E, Tarantini M, Rossi E, Bianchi C, Mezzanotte C, D'Angelo A: Antiphospholipid antibodies and risk of intrauterine late fetal death. Acta Obstet Gynecol Scand 1994, 73:389-392.

103

26.Branch DW, Silver RM, Blackwell L, Reading JC, Scott JR: Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol 1992, 80:614-620.

27.Branch DW, Andres R, Digre KB, Rote NS, Scott JR: The association of

28. Bick R. L. Recurrent miscarriage syndrom e and infertility caused by blood coagulation protein or platelet defects // Hematol. Oncol. Clin. North. Am. 2000.

Vol. 14, № 5. Р. 1117–1131.

29.Brenner B., Sarig G., Wetner Z., Younis J., Blumenfeld Z., Lanir N., Thrombophilic polymorphisms in women with fetal loss.// Thromb.Mac. 1999; 82: 6-9.

30.Bertand M E , Legrand V , Boland J, et al. Randomized multicenter comprasion of conventional anticoagulation versus antiplatel therapy in unplanned and elective coronary stenting. The Full Anticoagulation versus Aspirin and Ticlopidine ( FANTASTIC) Study.//Circulation,1998 ,98 p.1597-1603A

31. Brenner B, Sarig G, Weiner Z, Younis J, Blumenfeld Z, Lanir N: Thrombophilic polymorphisms are common in women with fetal loss without apparent cause. Thromb Haemost 1999, 82:6-9.

32.Dahlbäck B (July 2008). "Advances in understanding pathogenic mechanismsof thrombophilic disorders". Blood 112 (1):19–27.

33.Crowther MA, Kelton JG (2003). "Congenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposed classification system". Ann. Intern. Med.138 (2): 128–34.

34.Bick R. L. et al. Reccurent miscarriage: cause, evaluation and treatment //

Medscape Womens heath. 1998. Vol. 3, № 3. P. 2.

104

35.Cockett FB, Thomas ML, Negus D. Iliac vein compression: its relation to iliofemoral thrombosis and the post-thrombotic syndrome. BMJ 1967; 2:14–19

36.Rosendaal FR, Reitsma PH (July 2009). "Genetics of venous thrombosis". J. Thromb. Haemost. 7 Suppl 1: 301–4.

37.Dahlbäck B (July 2008). "Advances in understanding pathogenic mechanisms of thrombophilic disorders". Blood 112 (1):19–27.

38.Dahlback B: Inherited resistance to activated protein C, a major cause of

venous thrombosis, is due to a mutation in the factor V gene.

Haemostasis 1994, 24:139-151.

39.Dekker GA, Sibai BM: Etiology and pathophysiology of preeclampsia Current concepts. AJOG Review. Am J Obstet Gynecol 1998, 179:1359-1375.

40.Dizon-Townson DS, Nelson LM, Easton K, Ward K: The factor V Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol 1996, 175:902-5.

41.Dekker GA, de Vries JIP, Doelitzsch PM, Huijgens PC, Blomberg von BME, Jakobs C, Geijn van HP: Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 1995, 173:1042-1048.

42.Egeberg O (June 1965). "Inherited antithrombin deficiency causing thrombophilia". Thromb.Diath. Haemorrh. 13: 516–30.

43.Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP, et al.: A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995, 10:111-113.

105

44. Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C (November 1981). "Deficiency of protein C in congenital thrombotic disease". J. Clin. Invest. 68 (5):13703.

45. Greer IA: Thrombosis in Pregnancy: Maternal and Fetal Issues. Lancet 1999, 353:1258-1265.

46.Gerhardt A, Scharf RE, Beckmann MW, Struve S, Bender HG, Pillny M, Sandmann W, Zotz RB: Prothrombin and Factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med 2000, 342:374-380.

47.Greer IA: The Challenge of Thrombophilia in Maternal-Fetal Medicine. N Engl J Med 2000, 342:424-425.

48.Green JR: Placenta previa and abruptio placentae. In Maternal Fetal Medicine: Principles and Practice. Edited by Creasy RK, Resnik R. Philadelphia: W.B. Saunders; 1994::609-610.

49.Garrow TA. Purification , kinetic properties, and cDNA cloning of mammalian betainehomocysteine methyltranserase.// J Biol Chem 1996 271 .22831-22838

50.Greer IA. Thrombosis in pregnancy: maternal and fetal issues. Lancet 1999; 353:1258–1265

51.Ginsberg JS, Brill-Edwards P, Burrows RF, et al. DVT during pregnancy: leg and trimester of presentation. Thromb Haemost 1992; 67:519–520

52.Ginsberg JS, Kearon C, Douketis J, et al. D-dimer and impedance plethysmography in patients with suspected deep vein thrombosis: results of a management trial. Arch Intern Med 1997; 157:1077–1081

53.Hughes GR (October 1983). "Thrombosis, abortion, cerebral disease, and the lupus anticoagulant".Br. Med. J. (Clin Res Ed) 287 (6399): 1088–9.

106

54. Heit JA (2007). "Thrombophilia: common questions on laboratory assessment and management". Hematology Am. Soc. Hematol. Educ. Program 2007 (1): 127– 35.

55. Harris EN: Syndrome of the black swan. Br J Rheumatol 1987, 26:324-326.

56 .Hull RD, Raskob GF, Carter CJ. Serial IPG in pregnancy patients with clinically suspected DVT: clinical validity of negative findings. Ann Intern Med 1990; 112:663–667

57.Hull RD, Hirsh J, Carter C, et al. Diagnostic efficacy of IPG for clinically suspected DVT: a randomized trial. Ann Intern Med 1985; 102:21–28

58.Hull RD, Hirsh J, Sackett D, et al. Diagnostic efficacy of IPG in suspected venous thrombosis: an alternative to venography. N Engl J Med 1977; 296:1497–

1500

59.Infante-Rievard C, David M, Gauthier R, Ribard GE: Lupus anticoagulants, anticardiolipin antibodies and fetal loss. N Engl J Med 1991, 325:1063-1066.

60.Infante-Rievard C, David M, Gauthier R, Ribard GE: Lupus anticoagulants, anticardiolipin antibodies and fetal loss. N Engl J Med 1991, 325:1063-1066.

61.Kluijtmans LA, van den Heuvel LP, Boers GH, Frosst P, Stevens EM, van OostBA, den Heijer M, Trijbels FJ, Rozen R, Blom HJ: Molecular genetic analysis in mild hyperhomocystinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 1996, 58:35-41.

63. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, Fait G, Lessing JB:Increased frequency of the genetic thrombophilia in women with complications of pregnancy. N Eng J Med 1999, 340:9-13.

107

64.Kutteh W.H. Antiphospholipid antibodies and reproduction//J. Reprod. Immunol.1997. Vol.35.P.151-171.

65.Kutteh WH: Antiphospholipid antibody-associated recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996, 174:1584-1589.

66.Lensing AWA, Prandoni P, Brandjes D, et al. Detection of DVT by real-time B-mode ultrasonography. N Engl J Med 1989; 320:342–345

67.Middeldorp S, van Hylckama Vlieg A (August 2008). "Does thrombophilia

testing help in the clinical management of patients?". Br. J.

Haematol. 143 (3):321–35.

68.de Moerloose P, Boehlen F (April 2007). "Inherited thrombophilia in arterial disease: a selective review". Semin. Hematol. 44 (2): 106–13.

69.Maertinelli I, Sagghi E, Landi G, Taioli E, Duca F, Mannucci PM: High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in the user of oral contraceptives. N Engl J Med 1988, 338:1793-1797

70.McCully KS: Homocysteine and vascular disease. Nat Med 1996, 2:386-389.

71.Mayer EL, Jacobsen DW, Robinson K: Homocysteine and coronary atherosclerosis.J Am Coll Cardiol 1996, 27:517-527.

72. Many A, Schreiber L, Rosner S, Lessing JB, Eldor A, Kupferminc MJ: Pathologic features of the placenta in women with severe pregnancy complications and thrombophilia. Obstet-Gynecol 2001, 98:1041-1044.

73. MacLean MA, Cumming GP, McCall F, Walker ID, Wallter JJ: The prevalence of lupus anticoagulant and anticardiolipin antibodies in women with a history of first trimester miscarriages. BJOG 1994, 101:103-110.

108

74.Macklon NS, Greer IA. Venous thromboembolic disease in obstetrics and gynaecology: the Scottish experience. Scot Med J 1996; 41:83–86

75.Nagy B, Tóth T, Rigó JJR, Karádi I, Romics L, Papp Z: Detection of factor v Leiden in severe pre-eclamptic Hungarian women. Clin genet 1998, 53:478-481.

76.Nelson-Piercy C, Letsky EA, de Swiet M. Low-molecularweight heparin for obstetric thromboprophylaxis: experience of sixty-nine pregnancies in sixty-one women at high risk. Am J Obstet Gynecol 1997; 176:1062–1068

77.Out HJ, Bruinse HW, Christiaens GCML, van Vliet M, Meilof IF, de Groot PG, Smeenk RJ, Derksen RH: Prevalence of antiphospholipid antibodies in patients with fetal loss. Ann Rheum Dis 1991, 50:553-557.

78.Oshiro BT, Silver RM, Scott JR, Yu H, Branch DW: Antiphospholipid antibodies and fetal death.

Obstet Gynecol 1996, 87:489-493.

79.Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (November 1996). "A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis" (PDF). Blood 88 (10): 3698–703

80.Poort SR, Rosendaal FR, Reitsma PH, Bertina RM: A genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996, 88:36983703.

109

82.Petri M, Golbus M, Anderson R, Whiting-O'Keefe Q, Corash L, Hellmann D: Antinuclear antibody, lupus antiroagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. A controlled prospective study of fortyfour women. Arthritis Rheum 1987, 30:601-606.

83.Pampus van MG, van MP, Dekker GA, Wolf HW, Huijgens PC, Koopman

MMW, Blomberg BME, von Büller HR: High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia. Am J Obstet Gynecol 1999, 180:1146-1150.

85. Comp PC, Esmon CT (December 1984). "Recurrent venous thromboembolism in patients with a partial deficiency of protein S". N. Engl.J.Med. 311 (24):15258.

86.Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA (October 2010). "Antiphospholipid syndrome". Lancet 376 (9751): 1498–509.

87.Rosendaal FR, Reitsma PH (July 2009). "Genetics of venous thrombosis". J. Thromb. Haemost. 7 Suppl 1: 301–4.

88.Hughes GR (October 1983). "Thrombosis, abortion, cerebral disease, and the lupus anticoagulant".Br. Med. J. (Clin Res Ed) 287 (6399): 1088–9.

89.Roberts JM, Taylor RN, Musici TJ, Rodgers GM, Hubel CA, McLaughlin

90. Rigo J Jr, Nagy B, Fintor L, Tanyi J, Beke A, Karadi I, Papp Z: Maternal and neonatal outcome of preeclamptic pregnancies: the potential roles of factor V Leiden mutation and 5,10 methylenetetrahydrofolate reductase. HypertensPregnancy 2000, 19:163172.

110